Physiologically Based Pharmacokinetic Modeling of Drug Disposition in Rat and Human: A Fuzzy Arithmetic Approach

PurposeProbabilistic methods are insufficient for dealing with the vagueness inherent in human judgment of minimal data available during early drug development. We sought to use fuzzy set theory as a basis for quantifying and propagating vague judgment in a physiologically based pharmacokinetic (PBPK) model for diazepam disposition.Materials and MethodsFirst, using diazepam distribution data in rat tissues and fuzzy regression, we estimated fuzzy rat tissue-to-plasma partition coefficients (Kp’s). We scaled the coefficients prior to human PBPK modeling. Next, we constructed the fuzzy set of hepatic intrinsic clearance (CLint) by integrating CLint values measured in vitro from human hepatocytes. Finally, we used these parameters, and other physiological and biochemical information, to predict human diazepam disposition. We compared the simulated plasma kinetics with published concentration-time profiles.ResultsWe successfully identified rat Kp’s by fuzzy regression. The predicted rat tissue concentration-time contours enveloped the animal tissue distribution data. For the human PBPK model, the mean in vivo plasma concentrations were contained in the simulated concentration-time envelopes.ConclusionsWe present a novel computational approach for handling information paucity in PBPK models using fuzzy arithmetic. Our methodology can model the vagueness associated with human perception and interpretation of minimal drug discovery data.

[1]  Leontios J. Hadjileontiadis,et al.  Adaptive Neuro-Fuzzy Modeling of Poorly Soluble Drug Formulations , 2006, Pharmaceutical Research.

[2]  H. Trussell,et al.  Constructing membership functions using statistical data , 1986 .

[3]  C Eric Hack,et al.  Bayesian analysis of physiologically based toxicokinetic and toxicodynamic models. , 2006, Toxicology.

[4]  Patrick Poulin,et al.  Utility of physiologically based pharmacokinetic models to drug development and rational drug discovery candidate selection. , 2003, Toxicology letters.

[5]  Malcolm Rowland,et al.  Fuzzy Simulation of Pharmacokinetic Models: Case Study of Whole Body Physiologically Based Model of Diazepam , 2004, Journal of Pharmacokinetics and Pharmacodynamics.

[6]  David Moens,et al.  A survey of non-probabilistic uncertainty treatment in finite element analysis , 2005 .

[7]  W. Stallings,et al.  Fuzzy Set Theory versus Bayesian Statistics , 1977 .

[8]  R. Yager On a general class of fuzzy connectives , 1980 .

[9]  Heng Wang,et al.  Fuzzy linear regression models for assessing risks of cumulative trauma disorders , 1997, Fuzzy Sets Syst..

[10]  Yuichi Sugiyama,et al.  Prediction of the volumes of distribution of basic drugs in humans based on data from animals , 1984, Journal of Pharmacokinetics and Biopharmaceutics.

[11]  Debjani Chakraborty,et al.  A Linear Regression Model in Fuzzy Environment Based on S-Curve , 2009 .

[12]  James J. Buckley Decision Making Under Risk: A Comparison of Bayesian and Fuzzy Set Methods , 1983 .

[13]  Beth A Sproule,et al.  Fuzzy pharmacology: theory and applications. , 2002, Trends in pharmacological sciences.

[14]  Oflr Marom A Comparison of Numerical Methods , 2009 .

[15]  I. Nestorov,et al.  Development of a Whole Body Physiologically Based Model to Characterise the Pharmacokinetics of Benzodiazepines. 1: Estimation of Rat Tissue-Plasma Partition Ratios , 2004, Journal of Pharmacokinetics and Pharmacodynamics.

[16]  Yuichi Sugiyama,et al.  Utility of hepatocytes in predicting drug metabolism: comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[17]  Lotfi A. Zadeh,et al.  Fuzzy Sets , 1996, Inf. Control..

[18]  M. Delp,et al.  Physiological Parameter Values for Physiologically Based Pharmacokinetic Models , 1997, Toxicology and industrial health.

[19]  William S. Spector Handbook of Biological Data , 1956 .

[20]  D. Leahy,et al.  Progress in simulation modelling for pharmacokinetics. , 2003, Current topics in medicinal chemistry.

[21]  Ram R. Bishu,et al.  Evaluation of fuzzy linear regression models by comparing membership functions , 1998, Fuzzy Sets Syst..

[22]  Chiang Kao,et al.  Least-squares estimates in fuzzy regression analysis , 2003, Eur. J. Oper. Res..

[23]  Ivan Nestorov,et al.  Whole-body physiologically based pharmacokinetic models , 2007, Expert opinion on drug metabolism & toxicology.

[24]  M. Moor,et al.  Kinetics of distribution and adipose tissue storage as a function of lipophilicity and chemical structure. I. Barbiturates. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[25]  G. Grass,et al.  Physiologically-based pharmacokinetic simulation modelling. , 2002, Advanced drug delivery reviews.

[26]  D. Davidson,et al.  Naltrexone effects on diazepam intoxication and pharmacokinetics in humans , 1998, Psychopharmacology.

[27]  J. Houston,et al.  Incorporation of in vitro drug metabolism data into physiologically-based pharmacokinetic models. , 1997, Toxicology in vitro : an international journal published in association with BIBRA.

[28]  M. Bickel,et al.  Kinetics of distribution and adipose tissue storage as a function of lipophilicity and chemical structure. II. Benzodiazepines. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[29]  S. Stefánsson,et al.  Electroencephalographic effects and serum concentrations after intranasal and intravenous administration of diazepam to healthy volunteers. , 2001, British journal of clinical pharmacology.

[30]  Paolo Vicini,et al.  Simulating pharmacokinetic and pharmacodynamic fuzzy-parameterized models: a comparison of numerical methods , 2007, Journal of Pharmacokinetics and Pharmacodynamics.

[31]  James J. Buckley,et al.  Linear and non-linear fuzzy regression: Evolutionary algorithm solutions , 2000, Fuzzy Sets Syst..

[32]  Hong Tau Lee,et al.  Fuzzy regression model with fuzzy input and output data for manpower forecasting , 2001, Fuzzy Sets Syst..

[33]  T. Ross Fuzzy Logic with Engineering Applications , 1994 .

[34]  K H Antonin,et al.  Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat. , 1976, The Journal of pharmacology and experimental therapeutics.

[35]  R. Leggett,et al.  Reference values for resting blood flow to organs of man. , 1989, Clinical physics and physiological measurement : an official journal of the Hospital Physicists' Association, Deutsche Gesellschaft fur Medizinische Physik and the European Federation of Organisations for Medical Physics.

[36]  Yuichi Sugiyama,et al.  Prediction of diazepam disposition in the rat and man by a physiologically based pharmacokinetic model , 1983, Journal of pharmacokinetics and biopharmaceutics.

[37]  Malcolm Rowland,et al.  Physiologic modeling of cyclosporin kinetics in rat and man , 1991, Journal of Pharmacokinetics and Biopharmaceutics.

[38]  Lucien Duckstein,et al.  Fuzzy conceptual rainfall–runoff models , 2001 .

[39]  Michael Hanss,et al.  Applied Fuzzy Arithmetic , 2005 .

[40]  A. Gelman,et al.  Physiological Pharmacokinetic Analysis Using Population Modeling and Informative Prior Distributions , 1996 .

[41]  Malcolm Rowland,et al.  Uncertainty Analysis in Pharmacokinetics and Pharmacodynamics: Application to Naratriptan , 2005, Pharmaceutical Research.

[42]  W W MAPLESON,et al.  An electric analogue for uptake and exchange of inert gases and other agents. , 1963, Journal of applied physiology.

[43]  P. Bahr,et al.  Sampling: Theory and Applications , 2020, Applied and Numerical Harmonic Analysis.